Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Sreenath V. Sharma(Harvard University), Jeffrey Settleman(Enzo Life Sciences (United States))
Cited by 445
Related Papers
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k
Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
|Cancer Research|2008|403
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
|Proceedings of the National Academy of Sciences|2007|358